› 2hk5

X-ray diffraction
2Å resolution

Hck Kinase in Complex with Lck targetted Inhibitor PG-1009247

Released:
DOI: 10.2210/pdb2hk5/pdb
PDB entry 2hk5 coloured by chain, front view.
PDB entry 2hk5 coloured by chain, side view.
PDB entry 2hk5 coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).
Sabat M, VanRens JC, Laufersweiler MJ, Brugel TA, Maier J, Golebiowski A, De B, Easwaran V, Hsieh LC, Walter RL, Mekel MJ, Evdokimov A, Janusz MJ
Bioorg Med Chem Lett 16 5973-7 (2006)
PMID: 16997556

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:
Structure domain:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-140247 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Tyrosine-protein kinase HCK Chain: A
Molecule details ›
Chain: A
Length: 270 amino acids
Theoretical weight: 30.97 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: P08631 (Residues: 247-514; Coverage: 51%)
Gene name: HCK
Sequence domains: Protein tyrosine and serine/threonine kinase
Structure domains:

Ligands and Environments

1 bound ligand:
Ligand 1BM 1 x 1BM
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: APS BEAMLINE 22-ID
Spacegroup: P65
Unit cell:
a: 96.977Å b: 96.977Å c: 69.998Å
α: 90° β: 90° γ: 120°
R-values:
R R work R free
0.201 0.198 0.25
Expression system: Escherichia coli

Quick links

Citations

3 review citations

The therapeutic journey of benzimidazoles: a review.
Bansal et al. (2012)
2 more

4 mentions without citation

Predicting new indications for approved drugs using a proteochemometric method.
Dakshanamurthy et al. (2012)
3 more